Gene · 5270
Papers2,089
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,089
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Homologous recombination repair gene-based risk model predicts prognosis and immune microenvironment for primary lung cancer after previous malignancies. | J Gene Med | 2023 | 37243581 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer. | Oncol Lett | 2023 | 37216168 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. | EJHaem | 2023 | 37206290 | PubTator, text mining | PubMed |
| Vascular and Neural Invasion in Oral Squamous Cell Carcinoma: A Study in an Iranian Population. | Adv Biomed Res | 2023 | 37200766 | PubTator, text mining | PubMed |
| Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery. | Cancer Med | 2023 | 37199384 | PubTator, text mining | PubMed |
| Age and gender differences in narcissism: A comprehensive study across eight measures and over 250,000 participants. | J Pers Soc Psychol | 2023 | 37184962 | PubTator, text mining | PubMed |
| Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. | Front Pharmacol | 2023 | 37180709 | PubTator, text mining | PubMed |
| New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation. | Healthcare (Basel) | 2023 | 37174750 | PubTator, text mining | PubMed |
| Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages. | J Ovarian Res | 2023 | 37170143 | PubTator, text mining | PubMed |
| Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma. | BMC Surg | 2023 | 37165423 | PubTator, text mining | PubMed |
| Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis. | J Cancer Res Clin Oncol | 2023 | 37160811 | PubTator, text mining | PubMed |
| Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes. | Elife | 2023 | 37158593 | PubTator, text mining | PubMed |
| The under-appreciated world of the serpin family of serine proteinase inhibitors. | EMBO Mol Med | 2023 | 37158379 | PubTator, text mining | PubMed |
| A sensory memory processing system with multi-wavelength synaptic-polychromatic light emission for multi-modal information recognition. | Nat Commun | 2023 | 37156788 | PubTator, text mining | PubMed |
| "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions. | Front Cardiovasc Med | 2023 | 37153474 | PubTator, text mining | PubMed |
| Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states. | Nat Commun | 2023 | 37142563 | PubTator, text mining | PubMed |
| Effects of mixed oil emulsion on short-term clinical outcomes in premature infants: A prospective, multicenter, randomized controlled trial. | Eur J Clin Nutr | 2023 | 37138099 | PubTator, text mining | PubMed |
| Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma. | Front Oncol | 2023 | 37124542 | PubTator, text mining | PubMed |
| Primary Treatment for Clinically Early Cervical Cancer with Lymph Node Metastasis: Radical Surgery or Radiation? | Curr Med Sci | 2023 | 37115398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5270/papers?page=17